TGFB1 and type 1 diabetes mellitus: Encapsulation of transforming growth factor-beta 1 (TGF-β1) within PLGA has also been demonstrated to attenuate immune rejection in the context of allogeneic islet transplantation for type 1 diabetes treatment.